KLA
KLAC · NasdaqOptical Instruments & Lenses · Fiscal year ends Jun 30
KLA reported revenue of $13.6B in the fiscal year ended Jun 2026, up 11.7% from the year before. Net income was $4.8B. Operating cash flow of $4.1B less capital expenditure of $376M left free cash flow of $3.8B. Net debt was $4.2B.
Last 5 fiscal years
Revenue and net income
Income statement
| Fiscal year | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | Jun 2026 |
|---|---|---|---|---|---|
| Revenue | $9.2B | $10.5B | $9.8B | $12.2B | $13.6B |
| Cost of revenue | $3.6B | $4.2B | $3.9B | $4.8B | $5.3B |
| Gross profit | $5.6B | $6.3B | $5.9B | $7.4B | $8.3B |
| Research & development | $1.1B | $1.3B | $1.3B | $1.4B | $1.5B |
| Selling, general & admin | $860M | $986M | $970M | $1B | $1.1B |
| Interest expense | $160M | $297M | $311M | $302M | $284M |
| Pre-tax income | $3.5B | $3.8B | $3.2B | $4.6B | $5.6B |
| Income tax | $167M | $402M | $428M | $583M | $775M |
| Net income | $3.3B | $3.4B | $2.8B | $4.1B | $4.8B |
| Diluted EPS | 21.92 | 24.15 | 2.03 | 3.04 | 3.66 |
| Diluted shares | 152M | 140M | 1,362M | 1,338M | 1,320M |
Balance sheet
| Fiscal year | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | Jun 2026 |
|---|---|---|---|---|---|
| Cash & equivalents | $1.6B | $1.9B | $2B | $2.1B | $1.6B |
| Receivables | $1.8B | $1.8B | $1.8B | $2.3B | $2.9B |
| Inventory | $2.1B | $2.9B | $3B | $3.2B | $3.6B |
| Current assets | $7.2B | $8.4B | $10B | $10.7B | $12.4B |
| Net PP&E | $850M | $1B | $1.1B | $1.3B | $1.4B |
| Goodwill | $2.3B | $2.3B | $2B | $1.8B | $1.8B |
| Total assets | $12.6B | $14.1B | $15.4B | $16.1B | $18B |
| Payables | $443M | $371M | $359M | $459M | $624M |
| Deferred revenue | $1B | $1.2B | $1.8B | $1.7B | $1.5B |
| Current liabilities | $2.9B | $3.7B | $4.7B | $4.1B | $4.3B |
| Short-term debt | $0 | $0 | $750M | $0 | – |
| Long-term debt | $6.7B | $5.9B | $5.9B | $5.9B | $5.9B |
| Total liabilities | $11.2B | $11.2B | $12.1B | $11.4B | $11.6B |
| Shareholders' equity | $1.4B | $2.9B | $3.4B | $4.7B | $6.3B |
| Backlog (remaining obligations) | $13.1B | $11.4B | $9.8B | $7.9B | – |
Cash flow
| Fiscal year | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | Jun 2026 |
|---|---|---|---|---|---|
| Operating cash flow | $3.3B | $3.7B | $3.3B | $4.1B | $4.1B |
| Capital expenditure | $307M | $342M | $277M | $335M | $376M |
| Free cash flow | $3B | $3.3B | $3B | $3.7B | $3.8B |
| Depreciation & amortisation | $363M | $415M | $402M | $394M | $394M |
| Stock-based compensation | $127M | $171M | $213M | $265M | $310M |
| Acquisitions | $479M | $27M | $4M | $0 | $0 |
| Share buybacks | $4B | $1.3B | $1.7B | $2.1B | $2.3B |
| Dividends paid | $639M | $733M | $773M | $905M | $1.1B |
| Dividend per share | 4.20 | 5.20 | 0.56 | 0.68 | 0.80 |
Key ratios
| Fiscal year | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | Jun 2026 |
|---|---|---|---|---|---|
| Revenue growth (YoY) | – | 13.9% | −6.5% | 23.9% | 11.7% |
| EPS growth (YoY) | – | 10.2% | −91.6% | 49.8% | 20.4% |
| Gross margin | 61.0% | 59.8% | 60.0% | 60.9% | 61.3% |
| Net margin | 36.1% | 32.3% | 28.1% | 33.4% | 35.6% |
| Return on equityBlank when equity is negative | 237.0% | 116.0% | 82.0% | 86.6% | 76.1% |
| Free cash flow margin | 32.6% | 31.7% | 30.9% | 30.8% | 27.7% |
| Cash conversion (CFO ÷ net income) | 1.00x | 1.08x | 1.20x | 1.00x | 0.86x |
| Receivable days | 72 | 61 | 68 | 68 | 78 |
| Inventory days | 218 | 249 | 282 | 247 | 253 |
| Payable days | 45 | 32 | 33 | 35 | 43 |
| Debt ÷ equity | 4.75x | 2.02x | 1.97x | 1.25x | 0.93x |
| Net debtDebt − cash & equivalents; excludes investments; negative = net cash | $5.1B | $4B | $4.7B | $3.8B | $4.2B |
| Current ratio | 2.50x | 2.24x | 2.15x | 2.62x | 2.88x |
Recent filings
More in Optical Instruments & Lenses
Standardised figures from the company's XBRL filings with the SEC (10-K, 10-Q). Line items follow US GAAP tags, so a company's own statement layout may differ and some lines show “–” where the company does not report that item. Ratios are calculated from these figures. For education only; not investment advice or a recommendation.